欧洲肠内喂养配方奶粉市场 – 行业趋势及 2030 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

欧洲肠内喂养配方奶粉市场 – 行业趋势及 2030 年预测

  • Healthcare
  • Upcoming Report
  • Jul 2023
  • Europe
  • 350 页面
  • 桌子數: 220
  • 图号: 60

Europe Enteral Feeding Formula Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2023 –2030
Diagram Market Size (Base Year)
USD 6.47 Billion
Diagram Market Size (Forecast Year)
USD 9.64 Billion
Diagram CAGR
%
Diagram Major Markets Players
  • Nutricia
  • Hormel Foods Corporation
  • Medline Industries
  • Mead Johnson & Company LLC.
  • Nestlé Health Science

>欧洲肠内喂养配方市场,按产品(标准配方和疾病特定配方)、应用(肿瘤学、神经病学、重症监护、糖尿病、胃肠病学等)管饲类型(胃管喂养、鼻胃管喂养、胃造口管喂养和十二指肠或空肠管喂养)、阶段(成人和儿科)、最终用户(医院和长期护理机构)划分——行业趋势和预测到 2030 年。

欧洲肠内喂养配方市场

欧洲肠内喂养配方市场分析及规模

全球范围内类风湿性关节炎和哮喘患病率的上升、老年人口的增加、政府举措的增多、肥胖人口数量的增加、治疗方案的进步以及意识的提高都是扩大欧洲肠内营养配方市场的原因。当许多人为了过上更健康的生活方式而转向纯素饮食时,素食肠内营养配方的开发至关重要,因为它是一种素食友好的配方,素食肠内营养配方是最安全的素食关节补充剂之一。此外,不断增加的研发活动、正在进行的临床试验和新兴市场将在预测期内为欧洲肠内营养配方市场创造新的机会。

Data Bridge Market Research 分析称,欧洲肠内喂养配方奶粉市场在 2022 年的规模为 64.7 亿美元,到 2030 年将飙升至 96.4 亿美元,预计在预测期内的复合年增长率为 5.2%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的洞察外,Data Bridge Market Research 整理的市场报告还包括深度专家分析、患者流行病学、渠道分析、定价分析和监管框架。

欧洲肠内喂养配方市场范围和细分

报告指标

细节

预测期

2023 至 2030 年

基准年

2022

历史岁月

2021 (可定制为 2015-2020)

定量单位

收入(百万美元)、销量(单位)、定价(美元)

涵盖的领域

按产品(标准配方和疾病专用配方)、应用(肿瘤科、神经科、重症监护、糖尿病、胃肠病学及其他)、管饲类型(胃管饲、鼻胃管饲、胃造口管饲、十二指肠或空肠管饲)、阶段(成人和儿童)、最终用户(医院和长期护理机构)

覆盖国家

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

Nutricia (Netherlands), Hormel Foods Corporation (U.S), Medline Industries, Inc. (U.S), Mead, Johnson & Company, LLC. (U.S), Nestlé Health Science (Switzerland), Abbott (U.S), Meiji Holdings Co., Ltd. (Japan), Fresenius Kabi AG (Germany), B. Braun Melsungen AG (Germany), EuropeHealth Product Inc. (U.S), Trovita Health Science (U.S), Victus Inc. (U.S), Avanos Medical Inc. (U.S), Cardinal Health (U.S), Moog Inc (U.S), Conmed Corporation (U.S), Cook Medical (Indiana), among others

Market Opportunities

  • Increase in adoption of enteral feeding formulas
  • Rising support and awareness from the key market players on the nutrition of cancer patients

Market Definition

Enteral tube feeding is the introduction of nutrients by tubes into the gut or stomach for individuals who are unable to satisfy their nutritional needs or who are unable to absorb oral nutrients. Tubes such as the nasojejunal tube, gastrostomy, nasogastric tube, and jejunostomy are available for enteral feed formula. The many ways utilized to deliver the required nutrients are cost-effective, nutritious, and a viable alternative to the invasive procedure.

Europe Enteral Feeding Formula Market Dynamics

Drivers

  • Rising cases of chronic diseases across the globe

The primary drivers that have fuelled the market demand in the projection period are technological advancements in enteral feeding formula. For patients with surgical damage, lactose tolerance, burns, ulcers, and other problems, the formula, which is rooted in the body, mainly consists of different minerals and proteins such as fibres, vitamins, proteins, and others. With more preterm deliveries and the development of more technologically advanced enteral feeding formula, demand for enteral feeding formula has increased compared to the previous year. In addition, demand for enteral feeding formula has surged as people worldwide become more health concerned.

  • Rise in the geriatric population

Europe is witnessing a steady increase in the geriatric population, which has resulted in an increase in chronic diseases in the region. The EU-27's growing geriatric population (those aged 85 and up) has several consequences. The expense of providing proper health and long-term care is one of the primary areas of worry for the concerned authority, as extremely old people tend to require proportionally more social services. Furthermore, the senior population, which is affected by neurological disorders such as multiple sclerosis, stroke, and dementia that inhibit swallowing, is the largest target audience for this market.

  • Expansion in product portfolio

Major market players' development of product portfolios is credited with driving growth in the Europe market for enteral feeding formulae. Leading pharmaceutical and nutraceutical firms invest heavily in research and development (R & R&D), resulting in product breakthroughs moving the market forward. The advent of ready-to-drink (RTD) products, ready-to-use nutritional supplements, and improvements in tube quality are all contributing to the market's growth.

Opportunity

  • New product launches in the enteral feeding devices

In Europe, the enteral feeding devices market has seen new product introductions in recent years, and these unique product innovations are proving to be a part of the enteral feeding devices market's tremendous potential opportunities. Furthermore, technical advances and product innovations are some of the major factors driving the growth of the enteral feeding formula market. The market's growth is being aided by key players' diverse product portfolios and robust product developments. Some of the product categories that have gained traction in recent years include ready-to-drink (RTD), ready-to-use nutritional supplements, tube feed, and tube feed for certain specialized purposes.

Restraint/Challenge

  • Complications associated with enteral feeding devices

According to the National Center for Biotechnology Information of the U.S. National Library of Medicine, gastrostomy and/or jejunostomy feeding tubes are routinely implanted and used for long-term home enteral nutrition support. Although the insertion of these tubes is usually associated with modest morbidity, their long-term usage can lead to various difficulties and disorders that can impair quality of life and have considerable financial implications. These issues contribute to the region's limited growth in the Europe enteral feeding devices market.

This Europe enteral feeding formula market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the enteral feeding formula market contact Data Bridge Market Research for an Analyst Brief, our team will help you make an informed market decision to achieve market growth.

Recent Development

  • In December 2021, Nestlé Health Science created a website in collaboration with healthcare professionals to offer information and support at every phase of the disease. The company emphasized the value of nutrition as part of a new initiative to inform and support cancer patients and their caregivers

Europe Enteral Feeding Formula Market Scope

The Europe enteral feeding formula market is segmented on the basis of product, stage, type of tube feeding, indication and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

  • Standard formula
  • Disease-specific formula

Stage

  • Adult
  • Paediatric

Type of Tube Feeding

  • Gastric Tube Feeding
  • Nasogastric Tube Feeding
  • Gastrostomy Tube Feeding
  • Duodenal or Jejunal Tube Feeding

End-user

  • Hospitals
  • Cardiology
  • Neurology
  • Critical Care (ICU)
  • Oncology
  • Others
  • Home Care

Application

  • Oncology
  • Neurology
  • Critical Care
  • Diabetes,
  • Gastroenterology
  • others

Europe Enteral Feeding Formula Market Regional Analysis/Insights

The enteral feeding formula market is analyzed, and market size insights and trends are provided by country, product, stage, type of tube feeding, indication, and end-user.

The countries covered in the enteral feeding formula market report are Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe.

Germany is expected to dominate the enteral feeding formula market due to the presence of major key players, continuous technological development and increasing awareness towards health in this region. 

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测各个国家市场情景的一些指标。此外,在提供国家数据的预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的大量或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。   

医疗保健基础设施增长安装基础和新技术渗透

欧洲肠内喂养配方奶粉市场还为您提供每个国家/地区资本设备医疗保健支出增长、肠内喂养配方奶粉市场不同类型产品的安装基数、使用生命线曲线的技术的影响以及医疗保健监管情景的变化及其对肠内喂养配方奶粉市场的影响的详细市场分析。数据涵盖 2015-2021 年的历史时期。

竞争格局和肠内喂养配方市场份额分析

欧洲肠内喂养配方市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对欧洲肠内喂养配方市场的关注有关。

欧洲肠内喂养配方市场的一些主要参与者包括:

  • Nutricia(荷兰)
  • 荷美尔食品公司(美国)
  • Medline Industries, Inc.(美国)
  • 美赞臣公司(Mead Johnson & Company, LLC.)(美国)
  • 雀巢健康科学(瑞士)
  • 雅培(美国)
  • 明治控股株式会社(日本)
  • 费森尤斯卡比公司(德国)
  • B.Braun Melsungen AG(德国)
  • EuropeHealth Product Inc.(美国)
  • Trovita Health Science(美国)
  • Victus Inc.(美国)
  • Avanos Medical Inc.(美国)
  • 康德乐 (美国)
  • Moog Inc(美国)
  • Conmed Corporation(美国)
  • 库克医疗(印第安纳州)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The market is segmented based on , By Product (Standard Formulas and Disease-Specific Formulas), Application (Oncology, Neurology, Critical Care, Diabetes, Gastroenterology, and Others) Type of Tube Feeding (Gastric Tube Feeding, Nasogastric Tube Feeding, Gastrostomy Tube Feeding, and Duodenal or Jejunal Tube Feeding), Stage (Adult and Paediatric), End-User (Hospitals and Long Term Care Facilities) – Industry Trends and Forecast to 2030. .
The Europe Enteral Feeding Formula Market size was valued at USD 6.47 USD Billion in 2022.
The Europe Enteral Feeding Formula Market is projected to grow at a CAGR of 5.2% during the forecast period of 2023 to 2030.
The major players operating in the market include Nutricia, Hormel Foods Corporation, Medline Industries , Mead Johnson & Company LLC., Nestlé Health Science, Abbott, Meiji Holdings Co. , Fresenius Kabi AG, B. Braun Melsungen AG, EuropeHealth Product , Trovita Health Science, Victus , Avanos Medical , Cardinal Health, Moog , Conmed Corporation, Cook Medical,.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..